Determining the prevalence of severe asthma in children in UK primary care

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/50651
• EU PAS number:
  EUPAS50650
• Study ID:
  50651
• Official title and acronym:
  Determining the prevalence of severe asthma in children in UK primary care
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  It is a retrospective epidemiological database study that aims to determine the annual prevalence of severe asthma in children in the UK community using primary care data, and applying different criteria for defining severe asthma.
• Study status:
  Ongoing

Research institutions and networks

Networks

Respiratory Effectiveness Group (REG)

Belgium

Denmark

France

Germany

Greece

Hungary

Italy

Netherlands

Spain

Sweden

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 18/01/2023

Actual: 18/01/2023

Study start date

Planned: 12/06/2023

Actual: 28/06/2023

Date of final study report

Planned: 30/09/2024

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Sanofi

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable